SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Novacare (NOV) breaking out... -- Ignore unavailable to you. Want to Upgrade?


To: PekingYen who wrote (322)7/23/1998 2:00:00 PM
From: Todd D. Wiener  Read Replies (2) | Respond to of 420
 
Declining on low volume and no news, NOV looks like a great buying opportunity here. It is retesting its lows. Many health care providers are taking huge hits, both for regulatory problems and for poor business outlooks (Beverly, Vencor, etc.). NOV is in a different situation, as far as I know. The stock is being taken down in sympathy. The company is evaluating strategic alternatives that may result in the unlocking of an additional $5-10 in hidden value. Even based on project growth, the stock is undervalued.

Todd